Lupus Nexus Landmark Study: A Prospective Registry and Biorepository Read more about Lupus Nexus Landmark Study: A Prospective Registry and Biorepository
EIK1003-001 (IMP1734-101): A First-in-Human, Phase 1/2, Open-Label, Multicenter, Dose-Escalation, Dose-Optimization, and Dose-Expansion Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Ph Read more about EIK1003-001 (IMP1734-101): A First-in-Human, Phase 1/2, Open-Label, Multicenter, Dose-Escalation, Dose-Optimization, and Dose-Expansion Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Ph
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eos Read more about A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eos
A Phase IIIb, Randomized, Multicenter, Open-label Study To Assess The Efficacy of Durvalumab plus Tremelimumab versus Pembrolizumab In Combination With Platinum-Based Chemotherapy For First-Line Treat Read more about A Phase IIIb, Randomized, Multicenter, Open-label Study To Assess The Efficacy of Durvalumab plus Tremelimumab versus Pembrolizumab In Combination With Platinum-Based Chemotherapy For First-Line Treat
A Phase 3, Randomized, Open-Label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combi Read more about A Phase 3, Randomized, Open-Label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combi
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in "A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with Malignant Tumors Read more about A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in "A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with Malignant Tumors
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD) Read more about A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)
Tropomyosin Flexibility as a Target for Small Molecule Intervention in Thin Filament Mutations Read more about Tropomyosin Flexibility as a Target for Small Molecule Intervention in Thin Filament Mutations
Supplement: Training and Capacity Building to Strengthen Sexual and Gender Minority Health Research in India Read more about Supplement: Training and Capacity Building to Strengthen Sexual and Gender Minority Health Research in India
Regulation of SGK1-mediated Pathological Cardiac Hypertrophy by Non-Canonical ERAD Read more about Regulation of SGK1-mediated Pathological Cardiac Hypertrophy by Non-Canonical ERAD
